These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia. Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W. PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032 [Abstract] [Full Text] [Related]
3. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. Okan NA, Chalabaev S, Kim TH, Fink A, Ross RA, Kasper DL. mBio; 2013 Feb 12; 4(1):e00638-12. PubMed ID: 23404403 [Abstract] [Full Text] [Related]
4. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis. Jia Q, Horwitz MA. Front Cell Infect Microbiol; 2018 Feb 12; 8():154. PubMed ID: 29868510 [Abstract] [Full Text] [Related]
6. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge. Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA. Infect Immun; 2010 Oct 12; 78(10):4341-55. PubMed ID: 20643859 [Abstract] [Full Text] [Related]
7. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization. Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjöstedt A. Vaccine; 2010 Feb 17; 28(7):1824-31. PubMed ID: 20018266 [Abstract] [Full Text] [Related]
9. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain. Straskova A, Cerveny L, Spidlova P, Dankova V, Belcic D, Santic M, Stulik J. Microbes Infect; 2012 Feb 17; 14(2):177-87. PubMed ID: 21930232 [Abstract] [Full Text] [Related]
11. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence. Russo BC, Horzempa J, O'Dee DM, Schmitt DM, Brown MJ, Carlson PE, Xavier RJ, Nau GJ. Infect Immun; 2011 Sep 17; 79(9):3665-76. PubMed ID: 21670171 [Abstract] [Full Text] [Related]
12. An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy. Golovliov I, Lindgren H, Eneslätt K, Conlan W, Mosnier A, Henry T, Sjöstedt A. Front Cell Infect Microbiol; 2016 Sep 17; 6():152. PubMed ID: 27933275 [Abstract] [Full Text] [Related]
13. Francisella tularensis Live Vaccine Strain training of murine alveolar and bone marrow-derived macrophages. Khan H, Bhargava V, Elkins KL. Microbiol Spectr; 2024 Aug 06; 12(8):e0002824. PubMed ID: 38940590 [Abstract] [Full Text] [Related]
14. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy. Schmitt DM, O'Dee DM, Horzempa J, Carlson PE, Russo BC, Bales JM, Brown MJ, Nau GJ. PLoS One; 2012 Aug 06; 7(2):e31172. PubMed ID: 22355343 [Abstract] [Full Text] [Related]
15. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC. Infect Immun; 2006 Aug 06; 74(8):4452-61. PubMed ID: 16861631 [Abstract] [Full Text] [Related]